Dr. Florence K. Keane, MD
Radiation Oncology (Radiation Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Yale University School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 259
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: Yale University School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Radiation Oncology Physician primary
MA license 260603 -
Internal Medicine Physician
MA license L-248295
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
- Massachusetts General Hospital Boston, MA
- Newton-Wellesley Hospital Newton, MA
- Massachusetts Eye and Ear Infirmary - Boston, MA
- Martha's Vineyard Hospital Inc Oak Bluffs, MA
Medical groups
- Massachusetts General Physicians Organization Inc (3,558 clinicians)
- The General Hospital Corporation (1,267 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 259
- Services billed
- 2,488
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Ct guidance for insertion of radiation therapy fields | 1,184 | 88 |
| Calculation of radiation therapy dose | 706 | 117 |
| Design and construction of complex radiation treatment device | 527 | 125 |
| Radiation treatment management, 5 treatment sessions | 250 | 70 |
| Established patient office or other outpatient visit, 40-54 minutes | 154 | 128 |
| Complex radiation therapy planning | 132 | 126 |
| Established patient office or other outpatient visit, 30-39 minutes | 109 | 90 |
| Telephone medical discussion with physician, 21-30 minutes | 104 | 77 |
| 3d radiation therapy planning | 81 | 76 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 71 | 69 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Lorazepam Other prescribers in Boston, MA | 18 |
| Famotidine Other prescribers in Boston, MA | 16 |
| Dexamethasone Other prescribers in Boston, MA | 12 |
| Prednisone Other prescribers in Boston, MA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $15,237 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy SBRT with or without Pembrolizumab MK-3475 in Participants with Unresected Stage I or II N…
Merck Sharp & Dohme LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.